Lung cancer treatment is rapidly advancing. You may be on one or several of these types of standard treatments:
Some lung cancer patients find themselves looking for other treatment options after their initial (first-line) treatment. Your doctor may recommend one of the following as an additional line of treatment:
There are many approved chemotherapy drugs for lung cancer. You can ask your doctor which might be best for the type of lung cancer you have. You may receive chemotherapy in combination with immunotherapy.
- Maintenance Therapy
After completing chemotherapy, your doctor might recommend continuing chemotherapy to help maintain the body’s response to your first treatment.
- Targeted Therapy
If you have a biomarker with an approved targeted therapy and your first treatment doesn’t work or stops working, your doctor may want you to try a second-line targeted therapy for your particular biomarker.
Immunotherapy harnesses the power of a person’s immune system to fight the cancer. If you have advanced non-small cell lung cancer, you may be eligible for immunotherapy. You may receive immunotherapy in combination with chemotherapy.
- Clinical Trials
Clinical trials are carefully designed and monitored research studies. They may give you access to new and emerging treatments that are currently being studied. Participants in lung cancer trials either receive the best-known standard of care or a new therapy being tested. Read LUNG FORCE Hero Karen’s tips for entering a clinical trial and join the Lung Cancer Registry, which may help match you with clinical trials that might be right for your type of lung cancer.
Page last updated: January 25, 2021